These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 21918813)

  • 1. Delineating HIV-associated neurocognitive disorders using transgenic models: the neuropathogenic actions of Vpr.
    Power C; Hui E; Vivithanaporn P; Acharjee S; Polyak M
    J Neuroimmune Pharmacol; 2012 Jun; 7(2):319-31. PubMed ID: 21918813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence.
    Na H; Acharjee S; Jones G; Vivithanaporn P; Noorbakhsh F; McFarlane N; Maingat F; Ballanyi K; Pardo CA; Cohen EA; Power C
    Retrovirology; 2011 Jun; 8():44. PubMed ID: 21645334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 Vpr-Induced Proinflammatory Response and Apoptosis Are Mediated through the Sur1-Trpm4 Channel in Astrocytes.
    Li G; Makar T; Gerzanich V; Kalakonda S; Ivanova S; Pereira EFR; Andharvarapu S; Zhang J; Simard JM; Zhao RY
    mBio; 2020 Dec; 11(6):. PubMed ID: 33293383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative Temporal Viromics of an Inducible HIV-1 Model Yields Insight to Global Host Targets and Phospho-Dynamics Associated with Protein Vpr.
    Lapek JD; Lewinski MK; Wozniak JM; Guatelli J; Gonzalez DJ
    Mol Cell Proteomics; 2017 Aug; 16(8):1447-1461. PubMed ID: 28606917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus type 1 Vpr induces apoptosis in human neuronal cells.
    Patel CA; Mukhtar M; Pomerantz RJ
    J Virol; 2000 Oct; 74(20):9717-26. PubMed ID: 11000244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of HIV-1 Vpr on neuroinvasion and neuropathogenesis.
    Pomerantz RJ
    DNA Cell Biol; 2004 Apr; 23(4):227-38. PubMed ID: 15142380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 Vpr causes neuronal apoptosis and in vivo neurodegeneration.
    Jones GJ; Barsby NL; Cohen EA; Holden J; Harris K; Dickie P; Jhamandas J; Power C
    J Neurosci; 2007 Apr; 27(14):3703-11. PubMed ID: 17409234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific amino acids in HIV-1 Vpr are significantly associated with differences in patient neurocognitive status.
    Dampier W; Antell GC; Aiamkitsumrit B; Nonnemacher MR; Jacobson JM; Pirrone V; Zhong W; Kercher K; Passic S; Williams JW; James T; Devlin KN; Giovannetti T; Libon DJ; Szep Z; Ehrlich GD; Wigdahl B; Krebs FC
    J Neurovirol; 2017 Feb; 23(1):113-124. PubMed ID: 27400931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 Viral Protein R Activates NLRP3 Inflammasome in Microglia: implications for HIV-1 Associated Neuroinflammation.
    Mamik MK; Hui E; Branton WG; McKenzie BA; Chisholm J; Cohen EA; Power C
    J Neuroimmune Pharmacol; 2017 Jun; 12(2):233-248. PubMed ID: 27726055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of HIV-1 viral protein R-induced apoptosis.
    Muthumani K; Choo AY; Hwang DS; Chattergoon MA; Dayes NN; Zhang D; Lee MD; Duvvuri U; Weiner DB
    Biochem Biophys Res Commun; 2003 May; 304(3):583-92. PubMed ID: 12729593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-affinity interaction between HIV-1 Vpr and specific sequences that span the C/EBP and adjacent NF-kappaB sites within the HIV-1 LTR correlate with HIV-1-associated dementia.
    Burdo TH; Nonnemacher M; Irish BP; Choi CH; Krebs FC; Gartner S; Wigdahl B
    DNA Cell Biol; 2004 Apr; 23(4):261-9. PubMed ID: 15142383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 Vpr protein impairs lysosome clearance causing SNCA/alpha-synuclein accumulation in neurons.
    Santerre M; Arjona SP; Allen CN; Callen S; Buch S; Sawaya BE
    Autophagy; 2021 Jul; 17(7):1768-1782. PubMed ID: 33890542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin Treatment Prevents Neuroinflammation and Neuronal Injury with Restored Neurobehavioral Function in Models of HIV/AIDS Neurodegeneration.
    Mamik MK; Asahchop EL; Chan WF; Zhu Y; Branton WG; McKenzie BA; Cohen EA; Power C
    J Neurosci; 2016 Oct; 36(41):10683-10695. PubMed ID: 27733618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of NF-κB activity by HIV-1 Vpr is dependent on Vpr binding protein.
    Kogan M; Deshmane S; Sawaya BE; Gracely EJ; Khalili K; Rappaport J
    J Cell Physiol; 2013 Apr; 228(4):781-90. PubMed ID: 23001849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypophosphorylation of poly(A) polymerase and increased polyadenylation activity are associated with human immunodeficiency virus type 1 Vpr expression.
    Mouland AJ; Coady M; Yao XJ; Cohen EA
    Virology; 2002 Jan; 292(2):321-30. PubMed ID: 11878934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus viral protein R as an extracellular protein in neuropathogenesis.
    Ferrucci A; Nonnemacher MR; Wigdahl B
    Adv Virus Res; 2011; 81():165-99. PubMed ID: 22094081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How SLX4 cuts through the mystery of HIV-1 Vpr-mediated cell cycle arrest.
    Blondot ML; Dragin L; Lahouassa H; Margottin-Goguet F
    Retrovirology; 2014 Dec; 11():117. PubMed ID: 25496524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus core protein induces neuroimmune activation and potentiates Human Immunodeficiency Virus-1 neurotoxicity.
    Vivithanaporn P; Maingat F; Lin LT; Na H; Richardson CD; Agrawal B; Cohen EA; Jhamandas JH; Power C
    PLoS One; 2010 Sep; 5(9):e12856. PubMed ID: 20877724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunodetection of human immunodeficiency virus type 1 (HIV-1) Vpr in brain tissue of HIV-1 encephalitic patients.
    Wheeler ED; Achim CL; Ayyavoo V
    J Neurovirol; 2006 Jun; 12(3):200-10. PubMed ID: 16877301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 viral protein R causes peripheral nervous system injury associated with in vivo neuropathic pain.
    Acharjee S; Noorbakhsh F; Stemkowski PL; Olechowski C; Cohen EA; Ballanyi K; Kerr B; Pardo C; Smith PA; Power C
    FASEB J; 2010 Nov; 24(11):4343-53. PubMed ID: 20628092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.